ACETIC ACID 0.25% IN PLASTIC CONTAINER
Clinical safety rating
cautionComprehensive clinical and safety monograph for ACETIC ACID 0.25% IN PLASTIC CONTAINER (ACETIC ACID 0.25% IN PLASTIC CONTAINER).
Acetic acid acts as a bactericidal agent by lowering pH, disrupting bacterial cell membranes, and inhibiting bacterial growth. It also has antifungal properties.
| Metabolism | Acetic acid is metabolized via the tricarboxylic acid (TCA) cycle to carbon dioxide and water; minimal hepatic metabolism. |
| Excretion | Acetic acid 0.25% is a topical agent used for irrigation. Systemic absorption is negligible; any absorbed acetate is metabolized via the tricarboxylic acid cycle to CO2 and water. Less than 1% is excreted unchanged in urine. Fecal and biliary elimination are not relevant. |
| Half-life | Not applicable for systemic half-life due to minimal absorption. If absorbed, acetate has a half-life of approximately 5-10 minutes due to rapid metabolism. |
| Protein binding | Negligible (<1%) due to rapid metabolism and small amount absorbed. |
| Volume of Distribution | Not clinically relevant; with negligible systemic absorption, Vd is not defined for this formulation. |
| Bioavailability | Topical: not applicable (local effect). Oral/intravenous routes are not used; if ingested, acetate is rapidly metabolized. |
| Onset of Action | Topical irrigation: immediate upon contact with tissues (seconds to minutes). |
| Duration of Action | Topical irrigation: duration of action is limited to the period of contact; effects persist only while the solution is in contact with tissues. For antibacterial effect, activity is maintained during irrigation. |
| Molecular Weight | 60.05 |
Instill 5-15 mL into the bladder via catheter twice daily for 2-4 weeks.
| Dosage form | SOLUTION |
| Renal impairment | No dosage adjustment required for renal impairment. |
| Liver impairment | No dosage adjustment required for hepatic impairment. |
| Pediatric use | Safety and efficacy not established; no standard pediatric dosing. |
| Geriatric use | No specific dosage adjustment; use with caution due to potential for decreased renal function. |
| 1st trimester | Acetic acid 0.25% is considered safe for topical use during first trimester as systemic absorption is minimal. |
| 2nd trimester | No known fetal risk; topical use is safe. |
| 3rd trimester | No known fetal risk; topical use is safe. |
Clinical note
Comprehensive clinical and safety monograph for ACETIC ACID 0.25% IN PLASTIC CONTAINER (ACETIC ACID 0.25% IN PLASTIC CONTAINER).
| Placental transfer | Minimal systemic absorption occurs with topical application; thus, placental transfer is negligible. No significant fetal exposure expected. |
| Breastfeeding | Acetic acid 0.25% is a weak acid that is poorly absorbed systemically. Topical application is considered safe during breastfeeding. Avoid application to the breast if nipple fissures are present to prevent infant ingestion. |
| Lactation Rating | L1 (Safe) |
| Teratogenic Risk | Acetic acid at 0.25% concentration is not associated with teratogenicity. No fetal risks identified in any trimester. |
| Fetal Monitoring | No specific monitoring required for topical use. Systemic absorption is negligible. |
| Fertility Effects | No known effects on fertility. No reproductive toxicity data at this concentration. |
■ FDA Black Box Warning
No FDA boxed warnings.
| Serious Effects |
Hypersensitivity to acetic acid or any component of the formulationApplication to open wounds or severely damaged skin
| Precautions | For external use only; not for injection or ophthalmic use, May cause irritation or burns if used in high concentrations or on large wounds, Prolonged use may lead to overgrowth of non-susceptible organisms, Use with caution in patients with impaired renal function due to potential systemic absorption |
| Food/Dietary | None known; as a topical bladder irrigant, systemic absorption is negligible and no dietary restrictions are required. |
| Clinical Pearls | Acetic acid 0.25% is used as a bladder irrigant to prevent and treat catheter-associated urinary tract infections (CAUTIs) by acidifying urine and inhibiting urease-producing bacteria. Use with caution in patients with mucosal irritation or known hypersensitivity. Monitor for hematuria, dysuria, or bladder spasms. Not for systemic use; discard unused portions due to lack of preservatives. |
| Patient Advice | This solution is for bladder irrigation only and must not be injected or taken orally. · You may experience a mild burning sensation or bladder discomfort during irrigation. · Report any signs of allergic reaction (rash, itching, difficulty breathing) or severe pain immediately. · The solution is sterile; do not touch the container tip or reuse any leftover solution. |
Loading safety data…